1. A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron (PF‐06882961), an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, in Japanese adults with type 2 diabetes mellitus. Issue 3 (19th December 2022) Authors: Ono, Ryosuke; Furihata, Kenichi; Ichikawa, Yoshihiko; Nakazuru, Yoshiomi; Bergman, Arthur; Gorman, Donal N.; Saxena, Aditi R. Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 3(2023) Page Start: 805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗